Our findings that high levels of expression of PRPS2, SDC1 and also SLC7A6 are associated with poor clinical outcome in neuroblastoma, and that PRPS2 and SDC1 are important in proliferation, suggest that these genes may facilitate tumor progression in MYC- and MYCN-driven cancers. This evidence concerns the gene PRPS2 and cancer.